Drugplain

YUSIMRY 40 mg/.8mL

adalimumab-aqvh · INJECTION, SOLUTION · Coherus BioSciences Inc

No Recall History
Plain English

YUSIMRY is a injection, solution containing adalimumab-aqvh at 40 mg/.8mL, taken subcutaneous. Manufactured by Coherus BioSciences Inc.

Key Facts

Brand Name
YUSIMRY
Generic Name
adalimumab-aqvh
NDC Code (Product)
70114-210
Manufacturer
Coherus BioSciences Inc
Strength
40 mg/.8mL
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Marketing Status
Application #
BLA761216
Drug Class
Tumor Necrosis Factor Blocker [EPC]
Marketing Start
07/01/2023

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

accidental exposure to product34 reports
product dose omission issue31 reports
device malfunction26 reports
no adverse event14 reports
device leakage9 reports
product quality issue9 reports
product complaint6 reports
drug ineffective5 reports
incorrect dose administered4 reports
pain4 reports

Frequently Asked Questions

What is YUSIMRY used for?

YUSIMRY contains adalimumab-aqvh. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.

Is YUSIMRY a controlled substance?

YUSIMRY is not classified as a controlled substance by the DEA.

What is the generic name for YUSIMRY?

The generic name for YUSIMRY is adalimumab-aqvh. There are no other listed brand versions of adalimumab-aqvh.

What is the NDC code for YUSIMRY 40 mg/.8mL?

The NDC (National Drug Code) for YUSIMRY 40 mg/.8mL is 70114-210, listed by Coherus BioSciences Inc.

Product NDC

70114-210

Package NDC

70114-210-02

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)